ArticleFrontiers in immunology2023

Safety and efficacy of tislelizumab plus chemotherapy versus chemotherapy alone as neoadjuvant treatment for patients with locally advanced gastric cancer: real-world experience with a consecutive patient cohort.

Qi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.